SlidesetHIVGlobal HIV Clinical Forum 2020HIV Vaccines - Where Are We? - Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020Therapeutic approaches for a sustainable remission and cure - Steven Deeks, MDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020Starting Long-Acting Drugs in the COVID-19 Era - Anton Pozniak, MD, FRCPView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020Introducing New Therapies in Middle-Income Countries - Pedro Cahn, MD, PhDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020Strategies for Management of Drug-Drug Interactions With Long-Acting Therapies - David Back, PhDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020How and When to Monitor Patients On Long-Acting Antivirals? - Monica Gandhi, MD, MPHView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020Clinical Case: Reduced Drug Therapy - Mary Montgomery, MDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020Implications for Women's Health - Sharon Walmsley, MD, FRCPC, CMView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020Implications for Sanctuary Sites and Drug Interactions - Marta Boffito, MD, PhDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020Implications of Drug Resistance for the HIV Pandemic - Robert Shafer,MDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020Long Acting Injectable Antiretroviral Therapy - Martin Markowitz, MDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2020First-Line Therapy for HIV Infection - David Wohl, MDView Slideset